The co-occurrence of Guillain-Barre syndrome (GBS) and tuberculosis is rare. Even in countries like India, where tuberculosis is common, there is only one case report of co-occurrence of GBS with tuberculosis. We report a case of GBS in association with sputum-positive pulmonary tuberculosis. The earliest treatment with intravenous immunoglobulin in acute motor axonal neuropathy variant of GBS would show good early recovery despite associated pulmonary tuberculosis.
muscle action potentials (CMAPs), and conduction velocities were normal, and sensory nerve conduction parameters were normal [ Figure 2 ].
Her hematological and biochemical profile including complete blood count, serum electrolytes, liver function test, and renal function test were normal. Her erythrocyte sedimentation rate was increased at 26 mm/h. Serological tests for HIV, hepatitis B, and antinuclear antibody were negative. Urine analysis for porphobilinogen was negative. Chest X-ray showed bilateral parahilar lymphadenopathy. Sputum and bronchoalveolar lavage revealed the presence of acid-fast bacilli on microscopic examination with Ziehl-Neelsen staining. Cerebrospinal fluid (CSF) examination on the 2 nd day of symptom onset was normal. Magnetic resonance imaging (MRI) of brain and spine with contrast was normal [ Figure 3a and b].
The diagnosis of GBS was made she was treated with intravenous immunoglobulins (IVIG) on the 3 rd day of illness at a dose of 0.4 g/kg/day for 5 days and antitubercular drugs.
Repeat CSF study after 1 week of illness revealed albumin-cytological dissociation. Repeat nerve conduction studies after 10 days of onset showed decreased amplitudes of CMAPs with normal distal latencies and conduction velocities [ Figure 2 ].
Introduction
G uillain-Barre syndrome (GBS) is an acute, monophasic, symmetrically progressive, peripheral ascending demyelinating polyneuropathy characterized by rapidly evolving symmetrical limb weakness, areflexia, absent or mild sensory signs, and variable autonomic disturbances. It is the major cause of acute neuromuscular paralysis, with an annual incidence of 0.4-4/100,000 worldwide. The association of GBS with various gastrointestinal and respiratory tract infections is well established. [2] The peripheral nerve involvement in patients with tubercular infection is uncommon, [1] and it is attributed to malnutrition and neuropathic effects of antitubercular therapy. However, GBS in association with pulmonary tuberculosis is rarely described.
Case Report
A 16-year-old girl presented to us with acute onset, progressive, ascending, predominantly motor, quadriparesis with truncal weakness for the last 24 h. There was no facial or bulbar involvement. Bladder and bowel functions were normal. She was diagnosed to have pulmonary tuberculosis (sputum positive) 1 week prior to presentation and was taking antitubercular drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) since then.
On examination, she had symmetric, pure motor, areflexic, lower motor neuron-type quadriparesis (upper limb muscle power Medical Research Council [MRC] Grade III and lower limb MRC Grade II) without facial and bulbar involvement.
Nerve conduction studies done on the 2 nd day of onset of symptoms revealed absent H-reflexes from both soleus muscles. The F-wave studies showed absent or impersistent F-responses [ Figure 1 ]. Other motor nerve conduction parameters including distal latencies, amplitudes of compound Department of Neurology, Sri Aurobindo Medical College and PGI, Indore, Madhya Pradesh, India
Discussion
GBS is a postinfectious, immune-mediated disease. Both cellular and humoral immune mechanisms play a role in its pathogenesis. Many of the identified infectious agents are thought to trigger antibody production against ganglioside and glycolipids of myelin through molecular mimicry and cross-reactivity. [4] The co-occurrence of GBS and tuberculosis is rarely described in literature. In our case, a patient of sputum-positive pulmonary tuberculosis developed GBS subsequently.
In a review of 1100 cases of GBS, Leneman reported tuberculosis as an associated illness in only eight cases. [5] The review again highlights the rarity of this association. Peiris et al. reported a case in which tuberculous granulomata and the tubercle bacillus were demonstrated in the nerve roots at biopsy in a patient who presented with the salient features of GBS. Vyravanathan and Senanayake. reported two cases of tuberculosis with GBS, and they proposed that a cell-mediated hypersensitivity reaction, or invasion of the nerve root by tubercular bacilli, would seem to be the likely explanation of the neuropathy. [6] Patients of tubercular radiculomyelitis present with root pain, paresthesias, bladder disturbance, and muscle wasting; subsequent paralysis develops, usually after a few days. It is not uncommon to find absent deep tendon reflexes with flaccidity in the lower limbs and the presence of extensor plantar response. In our case, absence of signal changes, no contrast enhancement on MRI, and absence of inflammatory cells in CSF ruled out the possibility of tubercular radiculomyelitis. Further serial nerve conduction studies confirmed the diagnosis of axonal variant of GBS. The prognosis for recovery is worse in axonal variants of GBS as compared to demyelinating type. Canham and Iseman. reported a case of pulmonary tuberculosis associated with GBS, who recovered over 7 months after treatment with IVIG. [1] Despite medical treatment, GBS often remains a severe disease; about 3-10% of patients die and 20% are still unable to walk after 6 months. In addition, many patients have pain and fatigue that can persist for months or years. [3] Our case showed fast recovery after treatment, probably due to early start of therapy with IVIG, within the 1 st week of illness.
Taha et al. reported a case of GBS with unremitting cough and confirmed tubercular infection by bronchoscopy and bronchoalveolar lavage examination. [7] Early bronchoscopic sampling might be worth considering in patients with the suspicion of pulmonary infection since early treatment of specific infections may change the morbidity and mortality. Our patient too showed excellent response to IVIG therapy along with anti-tubercular drugs.
Conclusion
To the best of our knowledge, the patient we report is the one of the few cases of GBS with microbiological confirmation of pulmonary tuberculosis in a young Indian girl. It remains a question whether tuberculosis is a contributory factor in the development of GBS. Further possibility of tubercular radiculomyelitis in such cases makes the situation debatable. The reports of the co-occurrence of tuberculosis and GBS have been rarely published from different parts of the world in the past. We wish to draw the attention of clinicians and researchers to consider tuberculosis as a possible associated condition when evaluating patients with GBS.
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Tregs in the presence of anti-CD 3 and anti-CD8 antibodies which might be a candidate for clinical application in patients with Guillain-Barré syndrome.
Primary active disease or reactivation of tuberculosis infection occurs due to a failure of CD 4 T-cell immunity. Macrophages and dendritic cells play a main role in active infection, through the release of proinflammatory mediators (tumor necrosis factor-α, interleukin-1, -6, and -12) and inflammatory chemokines (CCL2, CXCL10), thus recruiting neutrophils, natural killer cells, CD 4 , CD 8 , and γδTand B-lymphocytes, each of them producing their own complement of cytokines and chemokines to amplify cellular recruitment and remodeling the infection site into the granuloma. As the granuloma progresses to cavitary lesions, an hypoxic environment is facilitated, resulting in uncontrolled bacterial replication, with immune evasion strategies, as described below: Host effector mechanisms are prevented by arresting phagolysosome biogenesis, thus creating an unfavorable intracellular environment. [5] As Mycobacterium tuberculosis is an intracellular pathogen, humoral immunity might have no protective effect or might contribute to immunopathology in active disease. In spite of the demonstration of raised titers of serum antibodies against mycobacterial antigens, no single antigen was universally recognized by serum from patients with active tuberculosis. Some clinical observations suggest an insignificant role for antibodies for tuberculosis, whereas others favor a role for humoral immunity in tuberculosis.
In spite of the fact that M. tuberculosis strongly stimulates humoral immunity in humans, studies so far have given conflicting results; therefore, more research is necessary. [6] The association of Guillain-Barré syndrome and tuberculosis is rare. The clinical picture is to some extent different from In this issue, readers will encounter the case of a 16-year-old girl who was admitted with acute flaccid quadriparesis with truncal weakness, 1 week after being diagnosed as having pulmonary tuberculosis and being started on antituberculous chemotherapy. The patient was diagnosed as having Guillain-Barré syndrome, acute motor axonal neuropathy variant, and improved after receiving immunoglobulin therapy. [1] The clinical presentation of Guillain-Barré syndrome consists of a rapidly progressive symmetrical weakness of the limbs, in a combination of areflexia or hyporeflexia. Sometimes, it can be manifested through cranial nerve involvement, sensory deficit, and ataxia. This is caused by the damage of peripheral nervous system and its barriers. The diagnosis is based on a combination of clinical features, nerve conduction studies, and cerebrospinal fluid analysis. [2] Guillain-Barré syndrome is a typical postinfectious disorder, which develops 1 month after a respiratory or gastrointestinal tract infection. This disorder is mainly humoral rather than T-cell mediated, driven by molecular mimicry between microbial and nerve molecules (better characterized for axonal variants and Miller-Fisher syndrome; less well understood for demyelinating variants). However, nerve-specific T-cells directed against unknown antigens might play a role in acute neuropathy. [3] Circulating CD 4 + -CD 25 + T-cells (Tregs) were studied in patients with Guillain-Barré syndrome. The number of Tregs was significantly decreased in peripheral blood in the acute stage of patients with Guillain-Barré syndrome and returned toward the level of healthy controls after intravenous immunoglobulin therapy. Therefore, reduced circulating Tregs might be associated with the pathogenesis of Guillain-Barré syndrome. [4] Interferon gamma was found to induce Commentary
